Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
1999 1
2000 2
2002 4
2003 4
2004 3
2005 1
2006 1
2007 2
2008 5
2009 4
2010 4
2011 3
2012 2
2013 8
2014 8
2015 5
2016 7
2017 15
2018 24
2019 8
2020 22
2021 11
2022 16
2023 12
2024 7
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Results by year

Filters applied: . Clear all
Page 1
Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: MAGNIFY-MS.
de Stefano N, Barkhof F, Montalban X, Achiron A, Derfuss T, Chan A, Hodgkinson S, Prat A, Leocani L, Schmierer K, Sellebjerg F, Vermersch P, Wiendl H, Keller B, Roy S; MAGNIFY-MS Study Group. de Stefano N, et al. Among authors: schmierer k. Neurol Neuroimmunol Neuroinflamm. 2022 Jun 14;9(4):e1187. doi: 10.1212/NXI.0000000000001187. Print 2022 Jul. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35701185 Free PMC article.
e-Health and multiple sclerosis: An update.
Lavorgna L, Brigo F, Moccia M, Leocani L, Lanzillo R, Clerico M, Abbadessa G, Schmierer K, Solaro C, Prosperini L, Tedeschi G, Giovannoni G, Bonavita S. Lavorgna L, et al. Among authors: schmierer k. Mult Scler. 2018 Nov;24(13):1657-1664. doi: 10.1177/1352458518799629. Epub 2018 Sep 19. Mult Scler. 2018. PMID: 30231004 Review.
MS care: integrating advanced therapies and holistic management.
Giovannoni G, Ford HL, Schmierer K, Middleton R, Stennett AM, Pomeroy I, Fisniku L, Scalfari A, Bannon C, Stross R, Hughes S, Williams A, Josephs S, Peel C, Straukiene A. Giovannoni G, et al. Among authors: schmierer k. Front Neurol. 2024 Jan 30;14:1286122. doi: 10.3389/fneur.2023.1286122. eCollection 2023. Front Neurol. 2024. PMID: 38351950 Free PMC article. Review.
Anaesthetic management of people with multiple sclerosis.
Dubuisson N, de Maere d'Aertrijcke O, Marta M, Gnanapavan S, Turner B, Baker D, Schmierer K, Giovannoni G, Verma V, Docquier MA. Dubuisson N, et al. Among authors: schmierer k. Mult Scler Relat Disord. 2023 Dec;80:105045. doi: 10.1016/j.msard.2023.105045. Epub 2023 Oct 11. Mult Scler Relat Disord. 2023. PMID: 37866022 Free article. Review.
Protecting people with multiple sclerosis through vaccination.
Reyes S, Ramsay M, Ladhani S, Amirthalingam G, Singh N, Cores C, Mathews J, Lambourne J, Marta M, Turner B, Gnanapavan S, Dobson R, Schmierer K, Giovannoni G. Reyes S, et al. Among authors: schmierer k. Pract Neurol. 2020 Dec;20(6):435-445. doi: 10.1136/practneurol-2020-002527. Epub 2020 Jul 6. Pract Neurol. 2020. PMID: 32632038 Review.
Cladribine: mechanisms and mysteries in multiple sclerosis.
Jacobs BM, Ammoscato F, Giovannoni G, Baker D, Schmierer K. Jacobs BM, et al. Among authors: schmierer k. J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1266-1271. doi: 10.1136/jnnp-2017-317411. Epub 2018 Jul 10. J Neurol Neurosurg Psychiatry. 2018. PMID: 29991490 Review.
No Evident Disease Activity-More Than a Risky Ambition?
Jacobs BM, Giovannoni G, Schmierer K. Jacobs BM, et al. Among authors: schmierer k. JAMA Neurol. 2018 Jul 1;75(7):781-782. doi: 10.1001/jamaneurol.2018.0829. JAMA Neurol. 2018. PMID: 29800951 Review. No abstract available.
157 results